Home About Agenda Speakers Register Location Committee

ICDD Committee

Salomon Stavchansky, Ph.D.
ICD2 Conference Scientific Chair
Alcon Centennial Professor of Pharmaceutics
The University of Texas at Austin College of Pharmacy

Linda S. Carter
Executive Vice-President, Regulatory Affairs
Greenleaf Health, LLC

Arthur A. Ciociola, Ph.D., F.A.C.G.
Vice President, Head of Global Regulatory Affairs
Alcon Research, Ltd.

Volker Fischer, Ph.D.
Vice President, DMPK
AbbVie Pharmaceutical

John M. Engel, Esq.
Founder and Managing Member
EngelNovitt, PLLC

Rick Friedman
Associate Director of Risk SC

Charles Hoiberg, Ph.D.
Executive Director
Pfizer, Inc

Kay Holcombe
Senior Vice President of Science Policy
Biotechnology Industry Organization (BIO)

Orest Hurko, M.D.
Senior Clinical Consultant
Biologics Consulting Group, Inc.

Kenneth I. Kaitin, Ph.D.
Professor and Director • Tufts Center for the Study of Drug Development
Tufts University

Chin Koerner, M.S.
Executive Director • Regulatory Policy
Novartis Pharmaceuticals

Joe Lamendola, Ph.D.
Vice President
Global Regulatory Sciences, US and Regulatory Policy
Bristol-Myers Squibb Company

Sau (Larry) Lee, Ph.D.
Acting Associate Director for Research Policy and Implementation

Alice E. Loper, Ph.D.
Head, Preclinical Development, Albiglutide
Biopharmaceutical Development

Samuel D. Maldonado, M.D., MPH, FAAP
Vice President & Head Pediatric Drug Development Center of Excellence
Johnson & Johnson

Andrea Masciale
Global Regulatory Policy & Intelligence
Janssen, Pharmaceutical Companies of Johnson and Johnson


Mehul Mehta, Ph.D.
Director, Division of Clinical Pharmacology I Office of Clinical Pharmacology

Robert J. Meyer, M.D.
Assc. Professor, Public Health Sciences Director
Inaugural Director of Virginia Center for Trnslational and Regulatory Sciences
University of Virginia School of Medicine

Terrance Ocheltree, Ph.D., R.Ph.
Sr Director Regulatory Affairs, CMC
Abbvie Pharmaceutical

Joanne Palmisano, M.D., FACP
Vice President • Drug Regulatory Affairs
Boehringer Ingelheim Pharmaceuticals, Inc.

Nicholas Pelliccione, Ph.D.
Vice President, Regulatory Affairs
Turing Pharmaceuticals

Sarah Pope Miksinski
Director (Acting), Office of New Drug Quality Assessment

Paula Rinaldi
North American Head of DRA
Novartis Pharmaceuticals

Maria Rivas, M.D.
Vice President
Global Medical Affairs, R & D
AbbVie Pharmaceutical

Jonathan Seltzer, M.D.
• ACI Clinical
Director of Clinical Research • Lankenau Heart Institute

Lisa A. Shipley, Ph.D.
Vice President & Global Head
Pharmacodynamics & Drug Metabolism
Merck & Co., Inc.

Alfred Tonelli, Ph.D.
Compound Development Leader
Johnson & Johnson PRD

Alan B. Watts, Ph.D.
Assistant Director, Drug Dynamics Institute
The University of Texas at Austin College of Pharmacy

Gerald J. Yakatan, Ph.D.
Founder & Chairman
IriSys, Inc.

Lawrence Yu, Ph.D.
Deputy Director (Acting)
Office of Pharmaceutical Science

Isaam Zineh, PharmD, MPH, FCP, FCCP
Director, Office of Clinical Pharmacology
Office of Translational Sciences

_ _

M. Lynn Crismon, Pharm.D., FCCP, BCCP
James T. Doluisio Regents Chair in Pharmacy Fellowship, Behrens Inc., Centennial Professor of Health Outcomes & Pharmacy Practice
The University of Texas at Austin College of Pharmacy

Conference Coordinator

Glen Baumgart, Ph.D.
Director • Continuing and Professional Education
The University of Texas at Austin College of Pharmacy

Last Reviewed: August 28, 2015

ACPE The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Comments to: UTPharmacyCE@austin.utexas.edu
Download free PDF Reader | Download free MS Reader
Privacy Policy | Accessibility Policy
©2012 College of Pharmacy, The University of Texas at Austin
Make a Gift